Derrell Porter
Director · Acumen Pharmaceuticals, Inc.
- 2026
- Jun 17, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Derrell Porter files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Lynx1 Capital Management LP - $206K in PASG purchases and sales in the last 12 months
- Derek M. Meisner - $105K in ABOS purchases and sales in the last 12 months
- William Chou - $75K in PASG purchases and sales in the last 12 months
- Kathleen Borthwick - $38K in PASG purchases and sales in the last 12 months
- Daniel Joseph Oconnell - $22K in ABOS purchases and sales in the last 12 months
- Nathan B. Fountain - $14K in ABOS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Derrell Porter?
Derrell Porter is a corporate insider, tracked as Director of Acumen Pharmaceuticals, Inc. (ABOS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Derrell Porter last file a Form 4?
The most recent primary Form 4 on record is dated 17 June 2026, one of 3 filings going back to 2026.
Has Derrell Porter been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($75K) across all tracked filings.
